Jeff Hall

The use of adjunctive artificial intelligence (AI) reportedly improved lesion level sensitivity by nearly 19 percent and patient level specificity by 14 percent for the diagnosis of clinically significant prostate cancer on multiparametric magnetic resonance imaging (MRI).

Regardless of experience level, radiologists are likely to be affected by automation bias when utilizing adjunctive artificial intelligence (AI) for mammography interpretation, according to newly published research.

In a recent video interview from the American Urological Association (AUA) 2023 Annual Meeting, Brian Helfand, M.D., discussed emerging research that shows the potential viability of the agent F18-rhPSMA-7.3 for enhancing the detection of prostate cancer recurrence and facilitating earlier intervention for patients with low prostate-specific antigen (PSA) levels.

An update to Quantib Prostate 2.1, Quantib Prostate 3.0 reportedly facilitates workflow advances and offers a variety of tools, ranging from artificial intelligence (AI)-based segmentation to PI-RADS scoring support, to help improve interpretation of prostate magnetic resonance imaging (MRI).

Revising a March 2022 recommendation, the Food and Drug Administration (FDA) said thyroid monitoring for young children three years of age and under receiving iodinated contrast media (ICM) in relation to contrast-enhanced computed tomography (CECT) can now be reserved for those with risk factors including prematurity, low birth weight or conditions affecting thyroid function.

The artificial intelligence (AI)-powered Neuro Suite reportedly enables radiologists to access leading neurological AI algorithm solutions in the field, including the brain magnetic resonance imaging (MRI) segmentation capabilities of the Combinostics’ algorithm that can help differentiate degenerative pathologies such as Alzheimer’s disease and dementia.

A hybrid computed tomography radiomics model demonstrated up to an 86 percent area under the curve in predicting microvascular invasion in patients with hepatocellular carcinoma in a recently published study.

Researchers suggested that overnight use of a power-save mode on outpatient magnetic resonance imaging (MRI) devices in the United States could reduce annual energy consumption by 76,288.2 megawatt hours (MWh) and add up to $10.7 million in cost savings.

The artificial intelligence (AI)-powered EchoGo Amyloidosis can reportedly detect cardiac amyloidosis by assessing a single echocardiogram.

While one computed tomography (CT) scan appears to have no elevated cancer risk in pediatric patients, four or more pediatric exposures to CT scans are associated with increased risks for intracranial tumor, leukemia, and non-Hodgkin lymphoma, according to newly published research out of Taiwan.

An emerging artificial intelligence (AI) software reportedly detected liver metastases in 53.7 percent of cases involving missed findings by radiologists.

In a new study involving over 11,700 chest computed tomography (CT) scans in oncology patients, adjunctive artificial intelligence software demonstrated a sensitivity rate of 91.6 percent for incidental pulmonary embolism (IPE) and reduced median detection and notification time for IPE-positive scans from multiple days to one hour for a radiology department at a comprehensive cancer center.

Emerging research looking at data from over 414,000 cases of breast cancer deaths suggests that Black women should begin annual mammography screening seven to nine years earlier than White women.

In a recent lecture at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting, Andrew Callen, M.D., discussed a variety of imaging features associated with cerebrospinal fluid (CSF) leaks, the diagnostic utility of the Bern score as well as the merits of 3D T2FS MRI and dynamic computed tomography myelography.

Earlier initiation of imaging after contrast administration with contrast-enhanced mammography may provide better visibility of lesions and conspicuity against background parenchymal enhancement, according to new research presented at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.

Powered by artificial intelligence (AI), the Rapid NCCT Stroke modality is reportedly the first medical device to gain FDA 510(k) clearance for detecting suspected large vessel occlusion and intracranial hemorrhage based on assessment of non-contrast computed tomography (NCCT).

Given the increasing prevalence of breast reconstruction, researchers discussed key signs of common complications on magnetic resonance imaging (MRI), ultrasound and other imaging during a recent presentation at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.

Three-dimensional (3D) slice-to-volume (SVR) fetal magnetic resonance imaging (MRI) has over six times the fetal optic pathway visualization rate of standard two-dimensional MRI, according to new research presented at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.

Recent research involving nearly 15,000 mammography exams in patients with a personal history of breast cancer revealed that digital breast tomosynthesis (DBT) was associated with a lower frequency of BI-RADS category 3 assessment and a lower malignancy rate for BI-RADS 3 lesions in comparison to full-field digital mammography.

Over the course of a decade, people with preexisting emphysema who continued smoking had the greatest decline in lung density, according to computed tomography (CT) findings from a study involving over 8,400 total participants and over 4,100 current smokers.

In addition to a previously FDA-cleared brain magnetic resonance imaging (MRI) module, the Advantis Platform features an artificial intelligence-powered prostate MRI module that offers simultaneous viewing of conventional and advanced sequences, and reportedly generates automated PI-RADS assessments.

In a study of over 1,200 men with over 3,200 prostatic lesions, an explainable artificial intelligence (AI) model demonstrated a sensitivity rate of 93 percent for detecting clinically significant prostate cancer.

The artificial intelligence (AI) triage and notification indications include acute subdural/epidural hematoma and acute subarachnoid hemorrhage for head computed tomography (CT) imaging.

The BD Prevue™ II Peripheral Vascular Access System reportedly offers real-time needle depth markers that may reduce multiple needlestick attempts and allow easier placement of intravenous (IV) access in high-risk patients.

New prospective research demonstrated that the combination of ultra-low-dose (ULD) computed tomography (CT) and an artificial intelligence (AI)-based denoising method offered a greater than 95 percent sensitivity rate for differentiating negative and actionable Lung-RADS category findings with significantly reduced radiation dosing.

A recent prospective study found that progression-free survival (PFS) and disease-specific survival (DSS) were significantly associated with breast cancer tumor treatment response on 2-(18F)FDG-PET/CT imaging in comparison to contrast-enhanced computed tomography (CT), which showed no evidence of a significant association with tumor response.

A recent study showed that artificial intelligence (AI)-based worklist reprioritization led to a mean reduction of 12.3 minutes in radiology report turnaround time for positive computed tomography pulmonary angiography (CTPA) exams that were positive for pulmonary embolism.

Emerging research suggests that 29 percent of patients with index breast magnetic resonance imaging (MRI) exams, 45 percent of Asian women and 30 percent of women living in the highest disadvantaged neighborhoods did not have follow-up imaging after a BI-RADS 3 diagnosis.

Based on a review of 3,495 echocardiographic studies to evaluate left ventricular ejection fraction (LVEF), researchers found that cardiologists changed initial artificial intelligence (AI) assessment 16.8 percent of the time and initial sonographer assessment 27.2 percent of the time.

Researchers found that ChatGPT offered appropriate responses to 22 out of 25 patient-oriented questions on mammography screening, dense breasts, BI-RADS scoring and other topics related to breast cancer screening and prevention.